Weiming Yue

1.1k total citations
49 papers, 812 citations indexed

About

Weiming Yue is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Weiming Yue has authored 49 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Weiming Yue's work include Lung Cancer Diagnosis and Treatment (11 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (7 papers). Weiming Yue is often cited by papers focused on Lung Cancer Diagnosis and Treatment (11 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (7 papers). Weiming Yue collaborates with scholars based in China, Germany and Italy. Weiming Yue's co-authors include Shuhai Li, Hui Tian, Libo Si, Lin Li, Cun Gao, Ming Lü, Hui Tian, Rongde Wu, Lei Qi and Wenjun Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Weiming Yue

47 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiming Yue China 17 394 192 180 162 158 49 812
Rosario Gil‐Benso Spain 19 330 0.8× 146 0.8× 176 1.0× 210 1.3× 87 0.6× 45 867
Charlotte E. Edling United Kingdom 14 606 1.5× 273 1.4× 124 0.7× 93 0.6× 141 0.9× 32 1.0k
Arata Nishimoto Japan 18 420 1.1× 174 0.9× 141 0.8× 86 0.5× 124 0.8× 36 802
Jean-Louis Kémény France 19 517 1.3× 154 0.8× 154 0.9× 145 0.9× 102 0.6× 37 859
Satoshi Kiyama Japan 16 599 1.5× 324 1.7× 329 1.8× 64 0.4× 118 0.7× 36 1.0k
Su-Peng Yeh Taiwan 13 533 1.4× 139 0.7× 213 1.2× 97 0.6× 58 0.4× 29 856
Claire Josse Belgium 20 590 1.5× 137 0.7× 438 2.4× 128 0.8× 104 0.7× 39 1.0k
Eckart Richter Germany 9 371 0.9× 184 1.0× 284 1.6× 272 1.7× 85 0.5× 15 972
Sang Hoon Shin South Korea 17 321 0.8× 224 1.2× 106 0.6× 388 2.4× 175 1.1× 47 1.1k
Jingyi Shi China 12 536 1.4× 183 1.0× 170 0.9× 227 1.4× 67 0.4× 32 1.1k

Countries citing papers authored by Weiming Yue

Since Specialization
Citations

This map shows the geographic impact of Weiming Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiming Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiming Yue more than expected).

Fields of papers citing papers by Weiming Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiming Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiming Yue. The network helps show where Weiming Yue may publish in the future.

Co-authorship network of co-authors of Weiming Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Weiming Yue. A scholar is included among the top collaborators of Weiming Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiming Yue. Weiming Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Ke, et al.. (2024). Unveiling Thymoma Typing Through Hyperspectral Imaging and Deep Learning. Journal of Biophotonics. 17(11). e202400325–e202400325. 1 indexed citations
2.
Yue, Weiming, Xiaohong Chen, Yongjie Wang, et al.. (2023). Circulating tumor DNA (ctDNA) methylation-based linkage regions to predict recurrence in early-stage lung cancer.. Journal of Clinical Oncology. 41(16_suppl). e20513–e20513.
3.
4.
Wang, Kun, et al.. (2022). Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma. SHILAP Revista de lepidopterología. 7 indexed citations
5.
Li, Zhenxiang, Qing Zhou, Qi Wang, Haiyong Wang, & Weiming Yue. (2022). EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers. BMC Pulmonary Medicine. 22(1). 356–356. 1 indexed citations
6.
Ma, Zheng, Jingyi Han, Weiming Yue, et al.. (2022). Comparison of the perioperative outcomes between robotic-assisted thoracic surgery and video-assisted thoracic surgery in non-small cell lung cancer patients with different body mass index ranges. Translational Lung Cancer Research. 11(6). 1108–1118. 11 indexed citations
7.
Wang, Kun, et al.. (2021). The effect of the enhanced recovery after surgery program on lung cancer surgery: a systematic review and meta-analysis. Journal of Thoracic Disease. 13(6). 3566–3586. 31 indexed citations
8.
9.
Si, Libo, Hui Tian, Weiming Yue, et al.. (2017). Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer. Oncology Letters. 14(4). 4325–4330. 25 indexed citations
10.
Tian, Hui, Weiming Yue, Lin Li, et al.. (2016). Rotenone induces apoptosis in human lung cancer cells by regulating autophagic flux. IUBMB Life. 68(5). 388–393. 30 indexed citations
11.
Li, Shuhai, Hui Tian, Weiming Yue, et al.. (2014). Clinical significance of miR-148a expression in patients with esophageal squamous cell cancer. 1(1). 48–52. 1 indexed citations
12.
Lü, Ming, Hui Tian, Weiming Yue, et al.. (2014). TFIIB-Related Factor 2 Over Expression Is a Prognosis Marker for Early-Stage Non-Small Cell Lung Cancer Correlated with Tumor Angiogenesis. PLoS ONE. 9(2). e88032–e88032. 23 indexed citations
13.
Tian, Hui, Weiming Yue, Lin Li, et al.. (2014). NCOA5 low expression correlates with survival in esophageal squamous cell carcinoma. Medical Oncology. 31(12). 376–376. 16 indexed citations
14.
Tang, Han, Weiming Yue, Lin Li, et al.. (2014). Overexpression of LAPTM4B is correlated with tumor angiogenesis and poor prognosis in non-small cell lung cancer. Medical Oncology. 31(6). 974–974. 22 indexed citations
15.
Li, Lin, Fengling Li, Hui Tian, et al.. (2014). Human mesenchymal stem cells with adenovirus-mediated TRAIL gene transduction have antitumor effects on esophageal cancer cell line Eca-109. Acta Biochimica et Biophysica Sinica. 46(6). 471–476. 9 indexed citations
16.
Lü, Ming, Hui Tian, Weiming Yue, et al.. (2013). Overexpression of TFIIB-related factor 2 is significantly correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer. Medical Oncology. 30(2). 553–553. 25 indexed citations
17.
Chen, Zhitao, Xiaohua Li, Hui Tian, et al.. (2012). Down-regulation of heparanase leads to the inhibition of invasion and proliferation of A549 cells <italic>in vitro</italic> and <italic>in vivo</italic>. Acta Biochimica et Biophysica Sinica. 45(3). 188–193. 5 indexed citations
18.
19.
Li, Lin, Hui Tian, Zhitao Chen, et al.. (2011). Inhibition of lung cancer cell proliferation mediated by human mesenchymal stem cells. Acta Biochimica et Biophysica Sinica. 43(2). 143–148. 48 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosario Gil‐Benso Breakdown of academic impact, for papers by Charlotte E. Edling Breakdown of academic impact, for papers by Arata Nishimoto Breakdown of academic impact, for papers by Jean-Louis Kémény Breakdown of academic impact, for papers by Satoshi Kiyama Breakdown of academic impact, for papers by Su-Peng Yeh Breakdown of academic impact, for papers by Claire Josse Breakdown of academic impact, for papers by Eckart Richter Breakdown of academic impact, for papers by Sang Hoon Shin Breakdown of academic impact, for papers by Jingyi Shi
Rankless by CCL
2026